Session

Stone metabolics and basic research

Poster Session 72

  • Location:
    Room Paris (Hall B2, level 0)
  • Chairs:
     A. Skolarikos, Athens (GR)
     Y-H. Sun, Shanghai (CN)
     C. Türk, Vienna (AT)
  • Aims and objectives of this session

    Stone removal means treatment of symptoms not causes. This session will give an update on what is going on in epidemiology, pathophysiology and metabolics of urinary stone disease.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
910
Food intake assessed by food dairy and PRODI6 analysis in Swiss kidney stone formers: Comparison to 24 hour urine excretion

By: Roth B.1, Mohebbi N.2, Fuster D.3, Kim M-J.4, Wagner C.A.2, Wuerzner G.5, Dhayat N.2, Bonny O.6

Institutes: 1University Hospital Berne, Dept. of Urology, Berne, Switzerland, 2University Hospital Zurich, Dept. of Urology and Nephrology, Zurich, Switzerland, 3University Hospital Berne, Dept. of Nephrology, Berne, Switzerland, 4University Hospital Basel, Dept. of Urology and Nephrology, Basel, Switzerland, 5University Hospital Geneva, Dept. of Urology and Nephrology, Geneva, Switzerland, 6University Hospital Lausanne, Dept. of Urology and Nephrology, Lausanne, Switzerland

911
Hypertension and renal impairment in patients with cystinuria: Findings from a specialist cystinuria centre

By: Kum F.1, Wong K.1, Game D.2, Glass J.1, Bultitude M.1, Thomas K.1

Institutes: 1Guy’s and St. Thomas’ Hospitals, London, Dept. of Urology, London, United Kingdom, 2Guy’s and St. Thomas’ Hospitals, London, Dept. of Nephrology, London, United Kingdom

912
The impact of uric acid stone components on renal function deterioration

By: Tanaka T., Noro D., Hatakeyama S., Terayama Y., Saitoh F., Saitoh H., Hashimoto Y., Koie T., Ohyama C.

Institutes: Hirosaki University Graduate School of Medicine, Dept. of Urology, Hirosaki, Japan

913
Upper urinary tract stone is an independent risk factor for stroke: A nation-wide population-based and with an 8-year follow-up study

By: Chung H.J.1, Lin A.T.1, Huang Y-H.1, Lin C-C.1, Fan Y-H.1, Chen T-J.2, Chen K-K.1

Institutes: 1Taipei Veterans General Hospital, Dept. of Urology, Taipei City, Taiwan, 2Taipei Veterans General Hospital, Dept. of Family Medicine, Taipei City, Taiwan

914
Do stones still kill? An analysis of death from stone disease 1999 to 2013 in England and Wales

By: Kum F., Mahmalji W., Hale J., Thomas K., Bultitude M., Glass J.

Institutes: Guy’s and St. Thomas’ Hospitals, Dept. of Urology, London, United Kingdom

915
Comparison of micro-elemental composition of the urinary stones in adult and pediatric patients

By: Abdel-Gawad Elnagar M.1, Elsobky E.2, Ali-El-Dein B.3

Institutes: 1Emirates International Hospital, Dept. of Urology and Radiology, Al-Ain, United Arab Emirates, 2Al-Noor Hospital, Dept. of Urology, Abu Dhabi, United Arab Emirates, 3Mansoura Urology and Nephrology Center, Dept. of Urology, Mansoura, Egypt

916
Murine model for the evaluation of hyperoxaluria on metabolic syndrome patients

By: Saenz J.1, Jorge E.2, Corbacho C.3, Santos M.4, Sanchez A.4, Soblechero P.2, Virumbrales E.2, Ramil E.4, Coronado M.J.4, Carballido J1

Institutes: 1Hospital Universitario Puerta De Hierro, Dept. of Urology, Majadahonda- Madrid, Spain, 2Hospital Universitario Puerta De Hierro, Dept. of Biochemistry, Majadahonda- Madrid, Spain, 3Hospital Universitario Puerta De Hierro, Dept. of Pathologic Anatomy, Majadahonda- Madrid, Spain, 4Hospital Universitario Puerta De Hierro, Dept. of Investigation, Majadahonda- Madrid, Spain

917
Potassium-sodium citrate prevents the progression of renal microcalculi into symptomatic stones in patients with calcium stones

By: Unno R.1, Taguchi K.2, Hamamoto S.2, Ando R.2, Okada A.2, Tozawa K.2, Kohri K.2, Yasui T.2

Institutes: 1Nagoya City University, Dept. Of Nephro-urology, Nagoya, Japan, 2Nagoya City University Graduate School of Medical Sciences, Dept. of Nephro-Urology, Nagoya, Japan

918
Papillary calcifications – a new prognostic factor in idiopathic calcium oxalate urolithiasis (CaOxU)

By: Strohmaier W.L.1, Hörmann M.1, Schubert G.2

Institutes: 1Klinikum Coburg, Dept. of Urology and Peadiatric Urology, Coburg, Germany, 2Labor Berlin Charité Vivantes, Urinary Stone Laboratory, Berlin, Germany

919
The role of M1/M2 macrophages for CaOx stone and Randall’s plaque formation

By: Taguchi K., Okada A., Hamamoto S., Unno R., Kamisawa H., Naiki T., Ando R., Umemoto Y., Itoh Y., Tozawa K., Kohri K., Yasui T.

Institutes: Nagoya City University Graduate School of Medical Sciences, Dept. of Nephro-Urology, Nagoya, Japan

920
Does matrix material affect urinary stone formation?

By: Elsobky E.1, Elnagar M.2, Ali-El-Dein B.3

Institutes: 1Al-Noor Hospital, Dept. of Urology, Abu Dhabi, United Arab Emirates, 2Emirates International Hospital, Dept. of Urology, Al Ain, United Arab Emirates, 3Mansoura Urology and Nephrology Center, Dept. of Urology, Mansoura, Egypt

921
Modified magnetic separation and enhanced Raman sensitivity for detecting urolithiasis via phosphonic acid-terminated Fe3O4 nanoclusters

By: Lin H-F1, Chiu Y-C.1, Chen P-A.2, Chang P-Y.2, Hsu C-Y.3, Tao C-W.2, Huang C-C.4, Chiang H.K.5

Institutes: 1Zhong Xiao Branch, Taipei City Hospital, Dept. of Urology and Surgery, Taipei, Taiwan, 2National Yang-Ming University, Institute of Biophotonics, Taipei, Taiwan, 3National Yang-Ming University, Institute of Biomedical Engineering, Taipei, Taiwan, 4National Cheng Kung University, Dept. of Photonics, Center For Micro/Nano Science and Technology and Advanced Optoelectronic Technology Center, Tainan, Taiwan, 5National Yang-Ming University, Biophotonics and Molecular Imaging Research Center (BMIRC), Taipei, Taiwan

922
Urolithiasis and osteopenia: Role of urinary citrate and magnésurie

By: Pierrard V.1, Puthet C.1, Lemoine S.1, Machon C.1, Dubourg L.1, Badet L.1, Martin X.1, Abid N.2

Institutes: 1Edouard Herriot Hospital, Lyon, France, 2Edouard Herriot Hospital, Urology, Lyon, France

Summary and context
 A. Skolarikos, Athens (GR)